Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 46981 - 47000 out of 558289 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (M05BX05) burosumab (adm: P) | Crysvita 20 mg/mL injection, 1 mL vial | Solution for injection 20 mg in 1 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia | KYOWAKIRINAUSTRALIAPTYLTD |
| Australia | (M05BX05) burosumab (adm: P) | Crysvita 20 mg/mL injection, 1 mL vial | Solution for injection 20 mg in 1 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia | KYOWAKIRINAUSTRALIAPTYLTD |
| Australia | (M05BX05) burosumab (adm: P) | Crysvita 20 mg/mL injection, 1 mL vial | Solution for injection 20 mg in 1 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia | KYOWAKIRINAUSTRALIAPTYLTD |
| Australia | (M05BX05) burosumab (adm: P) | Crysvita 20 mg/mL injection, 1 mL vial | Solution for injection 20 mg in 1 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia | KYOWAKIRINAUSTRALIAPTYLTD |
| Australia | (M05BX05) burosumab (adm: P) | Crysvita 30 mg/mL injection, 1 mL vial | Solution for injection 30 mg in 1 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia | KYOWAKIRINAUSTRALIAPTYLTD |
| Australia | (M05BX05) burosumab (adm: P) | Crysvita 30 mg/mL injection, 1 mL vial | Solution for injection 30 mg in 1 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia | KYOWAKIRINAUSTRALIAPTYLTD |
| Australia | (M05BX05) burosumab (adm: P) | Crysvita 30 mg/mL injection, 1 mL vial | Solution for injection 30 mg in 1 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia | KYOWAKIRINAUSTRALIAPTYLTD |
| Australia | (M05BX05) burosumab (adm: P) | Crysvita 30 mg/mL injection, 1 mL vial | Solution for injection 30 mg in 1 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia | KYOWAKIRINAUSTRALIAPTYLTD |
| Australia | (M05BX06) romosozumab (adm: P) | Evenity 105 mg/1.17 mL injection, 2 x 1.17 mL syringes | Injection 105 mg in 1.17 mL single use pre-filled syringe, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Osteoporosis | AmgenAustraliaPtyLimited |
| Australia | (M05BX06) romosozumab (adm: P) | Evenity 105 mg/1.17 mL injection, 2 x 1.17 mL syringes | Injection 105 mg in 1.17 mL single use pre-filled syringe, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Osteoporosis | AmgenAustraliaPtyLimited |
| Australia | (M05BX06) romosozumab (adm: P) | Evenity 105 mg/1.17 mL injection, 2 x 1.17 mL syringes | Injection 105 mg in 1.17 mL single use pre-filled syringe, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Osteoporosis | AmgenAustraliaPtyLimited |
| Australia | (M05BX06) romosozumab (adm: P) | Evenity 105 mg/1.17 mL injection, 2 x 1.17 mL syringes | Injection 105 mg in 1.17 mL single use pre-filled syringe, 2 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Osteoporosis | AmgenAustraliaPtyLimited |
| Australia | (M05BX06) romosozumab (adm: P) | Evenity 105 mg/1.17 mL injection, 2 x 1.17 mL syringes | Injection 105 mg in 1.17 mL single use pre-filled syringe, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Osteoporosis | AmgenAustraliaPtyLimited |
| Australia | (M05BX06) romosozumab (adm: P) | Evenity 105 mg/1.17 mL injection, 2 x 1.17 mL syringes | Injection 105 mg in 1.17 mL single use pre-filled syringe, 2 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Osteoporosis | AmgenAustraliaPtyLimited |
| Australia | (M05BX07) vosoritide | Voxzogo (10 x 400 microgram vials, 10 x 0.5 mL inert diluent syringes), 1 pack | Powder for injection 400 micrograms with diluent, 10 pcs | Retail price without vat |
$0-0 |
$0-0 |
Achondroplasia | BioMarinPharmaceuticalAustraliaPtyLtd |
| Australia | (M05BX07) vosoritide | Voxzogo (10 x 400 microgram vials, 10 x 0.5 mL inert diluent syringes), 1 pack | Powder for injection 400 micrograms with diluent, 10 pcs | Retail price without vat |
$0-0 |
$0-0 |
Achondroplasia | BioMarinPharmaceuticalAustraliaPtyLtd |
| Australia | (M05BX07) vosoritide | Voxzogo (10 x 400 microgram vials, 10 x 0.5 mL inert diluent syringes), 1 pack | Powder for injection 400 micrograms with diluent, 10 pcs | Retail price without vat |
$0-0 |
$0-0 |
Achondroplasia | BioMarinPharmaceuticalAustraliaPtyLtd |
| Australia | (M05BX07) vosoritide | Voxzogo (10 x 560 microgram vials, 10 x 0.7 mL inert diluent syringes), 1 pack | Powder for injection 560 micrograms with diluent, 10 pcs | Retail price without vat |
$0-0 |
$0-0 |
Achondroplasia | BioMarinPharmaceuticalAustraliaPtyLtd |
| Australia | (M05BX07) vosoritide | Voxzogo (10 x 560 microgram vials, 10 x 0.7 mL inert diluent syringes), 1 pack | Powder for injection 560 micrograms with diluent, 10 pcs | Retail price without vat |
$0-0 |
$0-0 |
Achondroplasia | BioMarinPharmaceuticalAustraliaPtyLtd |
| Australia | (M05BX07) vosoritide | Voxzogo (10 x 560 microgram vials, 10 x 0.7 mL inert diluent syringes), 1 pack | Powder for injection 560 micrograms with diluent, 10 pcs | Retail price without vat |
$0-0 |
$0-0 |
Achondroplasia | BioMarinPharmaceuticalAustraliaPtyLtd |
Pages
